NEW YORK (GenomeWeb News) – RainDance Technologies today said that the Genome Center at the Washington University School of Medicine in St. Louis has become the second early-access customer for the firm’s RDT 1000 instrument and Sequence Enrichment application, which are based on RainDance's RainStorm droplet-based technology platform.
RainDance will provide the instrument and customized PCR primer libraries to selectively amplify loci of interest for the center’s research initiatives. Elaine Mardis, co-director of the center, said that researchers there will apply the technology to large-scale targeted sequencing studies.
“It the technology delivers as promised, RainDance Technology stands to significantly advance the art of targeted sequencing,” Mardis said in a statement.
Washington University’s Genome Center is the second early-access customer for the technology, following the J. Craig Venter Institute, which was named as the first such customer last week.
RainDance said that it intends to commercially launch the platform in the first quarter of 2009.